read the financial statement -191million equity, plus 68 million SEC IPO at $3.60 5% discounted. So many mediocre phase 2 wanna be 3 cost so much cash ... Soon we will see ARRY executing on the 200 Million dollar deal they signed last month. I buy it when it finishs the plunge, for now I will be watching this cat bounce and bounce before it give it's last breath.
Array Biopharma (ARRY) Files $200M Mixed Shelf
7:09 AM ET, 12/21/2012 - Street Insider
Array Biopharma, Inc. (NASDAQ: ARRY) filed a registration with the U.S. SEC to sell, from time to time, up to $200 million of Common Stock, Preferred Stock, Depositary Shares, Debt Securities, Warrants, Units, or any combination thereof.
around 3.60 is a good price to buy, I'm not going to give easy money to MM who bought at 3.5 to make easy money on me. I have been in the market for sometime and have MBA too. Watch for big bulks of dumps as the day mature.